493
Views
48
CrossRef citations to date
0
Altmetric
Research Article

Artesunate-loaded chitosan/lecithin nanoparticles: Preparation, characterization, and in vivo studies

, &
Pages 1538-1546 | Received 28 Apr 2011, Accepted 13 Jan 2012, Published online: 20 Feb 2012

References

  • Klayman DL. (1985). Qinghaosu (artemisinin): an antimalarial drug from China. Science, 228:1049–1055.
  • World Health Organization. (2000). Trans. R. Soc Trop Med Hyg, 94 (1), 36.
  • Augustijns P, D’Hulst A, Van Daele J, Kinget R. (1996). Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells. J Pharm Sci, 85:577–579.
  • White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW et al. (1999). Averting a malaria disaster. Lancet, 353:1965–1967.
  • Akinlolu AA, Shokunbi MT. (2010). Neurotoxic effects of 25mg/kg/bodyweight of artemether on the histology of the trapezoid nuclei and behavioural functions in adult male Wistar rats. Acta Histochem, 112:193–198.
  • Titulaer HAC, Zuidema J, Lugt CB. (1991). Formulation and pharmacokinetics of arthemisinin and its derivatives. Int J Pharm, 69, 83–92.
  • Leite EA, Grabe-Guimarães A, Guimarães HN, Machado-Coelho GL, Barratt G, Mosqueira VC. (2007). Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. Life Sci, 80:1327–1334.
  • Song M, Li Y, Fai C, Cui S, Cui B. (2011). The controlled release of tilmicosin from silica nanoparticles. Drug Dev Ind Pharm, 37:714–718.
  • da Silva Santos NP, Nascimento SC, Wanderley MS, Pontes-Filho NT, da Silva JF, de Castro CM et al. (2006). Nanoencapsulation of usnic acid: An attempt to improve antitumour activity and reduce hepatotoxicity. Eur J Pharm Biopharm, 64:154–160.
  • Legrand P, Barratt G, Mosqueira V, Fessi H, Devissaguet JP. (1999). Polymeric nanocapsules as drug delivery systems: a review. S T P Pharm Sci, 9, 411–418.
  • Mosqueira VC, Legrand P, Morgat JL, Vert M, Mysiakine E, Gref R et al. (2001). Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res, 18:1411–1419.
  • Yue-Jian C, Juan T, Fei X, Jia-Bi Z, Ning G, Yi-Hua Z et al. (2010). Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Dev Ind Pharm, 36:1235–1244.
  • Xiao XC, Hong ZG. (2010). Firstborn microcrystallization method to prepare nanocapsules containing artesunate. Int J Nanomedicine, 5:483–486.
  • Hartell MG, Hicks R, Bhattacharjee AK, Koser BW, Carvalho K, Van Hamont JE. (2004). Nuclear magnetic resonance and molecular modeling analysis of the interaction of the antimalarial drugs artelinic acid and artesunic acid with beta-cyclodextrin. J Pharm Sci, 93:2076–2089.
  • Gabriëls M, Plaizier-Vercammen J. (2003). Physical and chemical evaluation of liposomes, containing artesunate. J Pharm Biomed Anal, 31:655–667.
  • Zhao KC, Xuan WY, Zhao Y, Song ZY. (1989). [The pharmacokinetics of a transdermal preparation of artesunate in mice and rabbits]. Yao Xue Xue Bao, 24:813–816.
  • Sonvico F, Cagnani A, Rossi A, Motta S, Di Bari MT, Cavatorta F et al. (2006). Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. Int J Pharm, 324:67–73.
  • Chadha R, Gupta S, Shukla G, Jain DVS, Pissurlenkar RRS, Coutinho EC. (2011) Interaction of artesunate with b-cyclodextrin: Characterization, thermodynamic parameters, molecular modeling, effect of PEG on complexation and antimalarial activity. Results in Pharma Sciences, 1, 38–48.
  • Shufang N, Shu Z, Weisan P, Yanli L. (2011) In vitro and in vivo studies on the complexes of glipizide with water soluble β-cyclodextrin-epichlorohydrin polymers. Drug Development and Industrial Pharmacy, 37(5), 606–612.
  • Magenheim B, Levy MY, Benita S. (1993). A new in vitro technique for the evaluation of drug release profile from colloidal carriers — ultra filtration technique at low pressure. Int J Pharm, 94, 115–123.
  • Hafner A, Lovric J, Voinovich D, Filipovic-Grcic J. (2009). Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm, 381:205–213.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.